Barbara Zagatti

1.7k total citations
17 papers, 1.2k citations indexed

About

Barbara Zagatti is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Barbara Zagatti has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Barbara Zagatti's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Barbara Zagatti is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Barbara Zagatti collaborates with scholars based in Italy, United States and Sudan. Barbara Zagatti's co-authors include Massimo Negrini, Manuela Ferracin, Laura Lupini, Angelo Veronese, Carlo M. Croce, Cristian Bassi, Elisa Callegari, Lucilla D’Abundo, Silvia Sabbioni and Laura Gramantieri and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.

In The Last Decade

Barbara Zagatti

17 papers receiving 1.2k citations

Peers

Barbara Zagatti

IMMUN

ONCOL

PFM

Tatjana Knyazeva Germany

Tong-Tao Yang China

Zengfu Xue China

Irina Elcheva United States

Xubin Deng China

Hakim Bouamar United States

Troels Schepeler Denmark

Harsha Prabhala United States

Lidia Moserle Italy

Fumihiko Matsuno Japan

Tatjana Knyazeva Germany

Barbara Zagatti

849 ×1.0

594 ×0.7

220 ×1.6

IMMUN

172 ×1.4

ONCOL

61 ×0.5

PFM

Citations per year, relative to Barbara Zagatti Barbara Zagatti (= 1×) peers Tatjana Knyazeva

Countries citing papers authored by Barbara Zagatti

Since Specialization

Citations

This map shows the geographic impact of Barbara Zagatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Zagatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Zagatti more than expected).

Fields of papers citing papers by Barbara Zagatti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Zagatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Zagatti. The network helps show where Barbara Zagatti may publish in the future.

Co-authorship network of co-authors of Barbara Zagatti

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Zagatti. A scholar is included among the top collaborators of Barbara Zagatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Zagatti. Barbara Zagatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Callegari, Elisa, Lucilla D’Abundo, Paola Guerriero, et al.. (2018). miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model. Molecular Therapy — Nucleic Acids. 11. 485–493. 75 indexed citations

Callegari, Elisa, Marco Domenicali, Ram C. Shankaraiah, et al.. (2018). MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer. Molecular Therapy — Nucleic Acids. 14. 239–250. 16 indexed citations

Ciancìo, Giovanni, Manuela Ferracin, Elena Saccenti, et al.. (2017). Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis.. PubMed. 35(1). 113–121. 36 indexed citations

Lupini, Laura, Felice Pepe, Manuela Ferracin, et al.. (2016). Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 7(21). 31361–31371. 46 indexed citations

Bresin, Antonella, Elisa Callegari, Lucilla D’Abundo, et al.. (2015). miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model. Oncotarget. 6(23). 19807–19818. 24 indexed citations

Mlčochová, Jitka, Petra Vychytilova‐Faltejskova, Manuela Ferracin, et al.. (2015). MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. Oncotarget. 6(36). 38695–38704. 60 indexed citations

Ferracin, Manuela, Laura Lupini, Elena Saccenti, et al.. (2015). Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget. 6(16). 14545–14555. 95 indexed citations

Ferracin, Manuela, Cristian Bassi, Massimo Pedriali, et al.. (2014). Abstract 4785: miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Cancer Research. 74(19_Supplement). 4785–4785. 2 indexed citations

Ferracin, Manuela, Cristian Bassi, Massimo Pedriali, et al.. (2013). miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Molecular Cancer. 12(1). 130–130. 71 indexed citations

10.

Lupini, Laura, Cristian Bassi, Manuela Ferracin, et al.. (2013). miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Frontiers in Genetics. 4. 64–64. 43 indexed citations

11.

Rigolin, Gian Matteo, Elena Saccenti, Lara Rizzotto, et al.. (2013). Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. Oncotarget. 5(1). 140–149. 7 indexed citations

12.

Callegari, Elisa, Bahaeldin K. Elamin, F.A. Giannone, et al.. (2012). Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology. 56(3). 1025–1033. 148 indexed citations

13.

Ferracin, Manuela, Massimo Pedriali, Angelo Veronese, et al.. (2011). MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐origin. The Journal of Pathology. 225(1). 43–53. 111 indexed citations

14.

Formica, Serena, Annalisa Astolfi, Margherita Nannini, et al.. (2011). MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype.. Journal of Clinical Oncology. 29(15_suppl). 10056–10056. 1 indexed citations

15.

Ferracin, Manuela, Barbara Zagatti, Lara Rizzotto, et al.. (2010). MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Molecular Cancer. 9(1). 88 indexed citations

16.

Santis, Giuseppe De, Manuela Ferracin, Andrea Biondani, et al.. (2010). Altered miRNA expression in T regulatory cells in course of multiple sclerosis. Journal of Neuroimmunology. 226(1-2). 165–171. 178 indexed citations

17.

Spizzo, Riccardo, Milena S. Nicoloso, Laura Lupini, et al.. (2009). miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells. Cell Death and Differentiation. 17(2). 246–254. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact